Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE004037 |
ID: | TCMBANKHE004037 |
植物拉丁名: |
|
功能与主治: | To remove toxic heat, and cause diuresis./Edema, beriberi, jaundice, strangury-turbidity, vaginal discharge, swollen welling abscess, clove sore. |
药用植物名: | 三白草 |
药用部位: | rhizome or whole plant |
治疗类型: | 利水渗湿药 |
TCM_ID_id: | 3085 |
SymMap_id: | 343 |
TCMSP_id: | 1033 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000014 | britanin | acetic acid [(3aS,5R,5aS,6R,8S,8aS,9S,9aR)-6-acetoxy-8-hydroxy-5,8a-dimethyl-1-methylene-2-oxo-4,5,5a,6,7,8,9,9a-octahydro-3aH-azuleno[6,5-b]furan-9-yl] ester; Britanin; ZINC4073932; MolPort-002-524-486; MCULE-4724847409; [(3aS,5R,5aS,6R,8S,8aS,9S,9aR)-6-acetyloxy-8-hydroxy-5,8a-dimethyl-1-methylidene-2-oxo-4,5,5a,6,7,8,9,9a-octahydro-3aH-azuleno[6,5-b]furan-9-yl] ethanoate; 1212165-89-3; AKOS030501992; BG01654699; acetic acid [(3aS,5R,5aS,6R,8S,8aS,9S,9aR)-6-acetoxy-8-hydroxy-2-keto-5,8a-dimethyl-1-methylene-4,5,5a,6,7,8,9,9a-octahydro-3aH-azuleno[5,6-d]furan-9-yl] ester; [(3aS,5R,5aS,6R,8S,8aS,9S,9aR)-6-acetoxy-8-hydroxy-5,8a-dimethyl-1-methylene-2-oxo-4,5,5a,6,7,8,9,9a-octahydro-3aH-azuleno[6,5-b]furan-9-yl] acetate; (3AR,4S,4AS,5R,7S,7AS,8R,9AS)-7-(ACETYLOXY)-5-HYDROXY-4A,8-DIMETHYL-3-METHYLIDENE-2-OXO-OCTAHYDRO-3AH-AZULENO[6,5-B]FURAN-4-YL ACETATE; STOCK1N-50176; [(3aS,5R,5aS,6R,8S,8aS,9S,9aR)-6-acetyloxy-8-hydroxy-5,8a-dimethyl-1-methylidene-2-oxo-4,5,5a,6,7,8,9,9a-octahydro-3aH-azuleno[6,5-b]furan-9-yl] acetate; C19H26O7 | C19H26O7 | 366.4 g/mol | CC1CC2C(C(C3(C1C(CC3O)OC(=O)C)C)OC(=O)C)C(=C)C(=O)O2 |
| TCMBANKIN000042 | isolinderalactone | NP-013327; ACN-047352; (3aS,4R,8bR)-4-ethenyl-4,8-dimethyl-3-methylidene-5,8b-dihydro-3aH-furo[2,3-e][1]benzofuran-2-one; 957-66-4; CHEBI:69073; AKOS032946064; AK687125; BDBM50359989; AC1NSX1X; Isolinderalactone; ZINC13532023; CHEMBL1927943 | C15H16O3 | 244.28 g/mol | CC1=COC2=C1C3C(C(=C)C(=O)O3)C(C2)(C)C=C |
| TCMBANKIN000061 | gaillardin | NSC220533; Gaillardin; PLENIRADIN ACETATE; [(3aS,5aS,6S,8R,8aR,9aR)-8-hydroxy-5,8-dimethyl-1-methylidene-2-oxo-5a,6,7,8a,9,9a-hexahydro-3aH-azuleno[6,5-b]furan-6-yl] ethanoate; NSC-220533; (8-hydroxy-5,8-dimethyl-1-methylidene-2-oxo-5a,6,7,8a,9,9a-hexahydro-3aH-azuleno[6,5-b]furan-6-yl) acetate; [(3aS,5aS,6S,8R,8aR,9aR)-8-hydroxy-5,8-dimethyl-1-methylidene-2-oxo-5a,6,7,8a,9,9a-hexahydro-3aH-azuleno[6,5-b]furan-6-yl] acetate; 25873-32-9; 5-HYDROXY-5,8-DIMETHYL-3-METHYLIDENE-2-OXO-3AH,4H,4AH,6H,7H,7AH,9AH-AZULENO[6,5-B]FURAN-7-YL ACETATE; acetic acid [(3aS,5aS,6S,8R,8aR,9aR)-8-hydroxy-5,8-dimethyl-1-methylene-2-oxo-5a,6,7,8a,9,9a-hexahydro-3aH-azuleno[6,5-b]furan-6-yl] ester; acetic acid [(3aS,5aS,6S,8R,8aR,9aR)-8-hydroxy-2-keto-5,8-dimethyl-1-methylene-5a,6,7,8a,9,9a-hexahydro-3aH-azuleno[5,6-d]furan-6-yl] ester; C09455; NSC106394; 14682-46-3; [(3aS,5aS,6S,8R,8aR,9aR)-8-hydroxy-5,8-dimethyl-1-methylene-2-oxo-5a,6,7,8a,9,9a-hexahydro-3aH-azuleno[6,5-b]furan-6-yl] acetate; DTXSID90309978; AC1L7KNV | C17H22O5 | 306.4 g/mol | CC1=CC2C(CC3C1C(CC3(C)O)OC(=O)C)C(=C)C(=O)O2 |
| TCMBANKIN004019 | isolinderxide | ||||
| TCMBANKIN005216 | iaurolitsine | ||||
| TCMBANKIN005838 | macrostemonoside v | ||||
| TCMBANKIN006826 | linderene acetate | C17H20O3 | 272.34 g/mol | CC1=COC2=C1C(C3C(=C)C4CC4C3(C2)C)OC(=O)C | |
| TCMBANKIN007599 | Carboceric acid | H6514_SIGMA; EINECS 230-436-9; ST5412086; HEPTACOSANOIC ACID; (C24-C44) alpha olefins, propionic acid reaction product; 68439-87-2; LMFA01010027; 7138-40-1; 51570_FLUKA; Carboxylic acids, C27-47 | C27H54O2 | 410.7 g/mol | CCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)O |
| TCMBANKIN007864 | inulin | Inulin; I0041 | C66H112O56 | 1801.6 g/mol | C(C1C(C(C(C(O1)OC2(C(C(C(O2)CO)O)O)COC3(C(C(C(O3)CO)O)O)COC4(C(C(C(O4)CO)O)O)COC5(C(C(C(O5)CO)O)O)COC6(C(C(C(O6)CO)O)O)COC7(C(C(C(O7)CO)O)O)COC8(C(C(C(O8)CO)O)O)COC9(C(C(C(O9)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)CO)O)O)O)O |
| TCMBANKIN008506 | lindleyin | AK608339; SC-73175; Lindleyin; [(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[4-(3-oxobutyl)phenoxy]tetrahydropyran-2-yl]methyl 3,4,5-trihydroxybenzoate; [(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[4-(3-oxobutyl)phenoxy]oxan-2-yl]methyl 3,4,5-trihydroxybenzoate; AC1L28Y7; ZINC31983781; Benzoic acid, 3,4,5-trihydroxy-, 6'-ester with 4-(4-(beta-D-glucopyranosyloxy)phenyl)-2-butanone; 59282-56-3; 4-(4'-Hydroxyphenyl)-2-butanone-4'-O-beta-D-(6''-O-gallyl)glucopyranoside; LS-38403; (4-(4'-Hydroxyphenyl)-2-butanone-4'-O-beta-D-(6''-O-gallyl)glucopyranoside); AKOS030573613; BRN 1672532 | C23H26O11 | 478.4 g/mol | CC(=O)CCC1=CC=C(C=C1)OC2C(C(C(C(O2)COC(=O)C3=CC(=C(C(=C3)O)O)O)O)O)O |
| TCMBANKIN008738 | Lindenene | lindenene | C15H18O | 214.3 | CC1=COC2=C1CC3C(=C)C4CC4C3(C2)C |
| TCMBANKIN008987 | isolinderalacfone | ||||
| TCMBANKIN011484 | taraxasteryl plmitate | ||||
| TCMBANKIN011744 | macrostemonoside k | C46H78O20 | 951.1 g/mol | CC1C2C(CC3C2(CCC4C3CCC5C4(CC(C(C5)OC6C(C(C(C(O6)CO)O)O)OC7C(C(C(C(O7)CO)O)O)O)O)C)C)OC1(CCC(C)COC8C(C(C(C(O8)CO)O)O)O)OC | |
| TCMBANKIN012070 | (?)-saucerneol methyl ether | C33H42O8 | 566.7 g/mol | CC1C(C(OC1C2=CC(=C(C=C2)OC)OC)C3=CC(=C(C=C3)OC(C)(C)C(C4=CC(=C(C=C4)OC)OC)O)OC)C | |
| TCMBANKIN014229 | macrostemonoside j | C45H76O20 | 937.1 g/mol | CC1C2C(CC3C2(CCC4C3CCC5C4(CC(C(C5)OC6C(C(C(C(O6)CO)O)O)OC7C(C(C(C(O7)CO)O)O)O)O)C)C)OC1(CCC(C)COC8C(C(C(C(O8)CO)O)O)O)O | |
| TCMBANKIN015131 | linderoxide | C16H20O2 | 244.33 | CC12CC3=C(CC1C(=C)C4C2C4)C(=CO3)COC | |
| TCMBANKIN015367 | linderenonelinderol | ||||
| TCMBANKIN016625 | inlulicin | ||||
| TCMBANKIN017107 | linderane | I07-0154; linderane ,98%; 476L250; MolPort-005-945-803; NP-013326; 13476-25-0; Linderane; CHEBI:6474; CHEMBL1079723; linderane(rg); C09495; ZINC898605; N1480; AKOS015896801 | C15H16O4 | 260.29 | CC1=CCCC23C(O2)C(C4=C(C1)OC=C4C)OC3=O |
| TCMBANKIN018001 | dehydrologanin | METHYL 7-METHYL-6-OXO-1-{[(2S,3R,4S,5S,6R)-3,4,5-TRIHYDROXY-6-(HYDROXYMETHYL)OXAN-2-YL]OXY}-1H,4AH,5H,7H,7AH-CYCLOPENTA[C]PYRAN-4-CARBOXYLATE | C17H24O10 | 388.4 g/mol | CC1C2C(CC1=O)C(=COC2OC3C(C(C(C(O3)CO)O)O)O)C(=O)OC |
| TCMBANKIN018602 | macrostemonoside vi | ||||
| TCMBANKIN019610 | Quercitrin-2'-gallate | quercitrin-2'-gallate; [(2R,3S,4S,5S,6R)-2-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-chromen-3-yl]oxy-4,5-dihydroxy-6-methyl-tetrahydropyran-3-yl] 3,4,5-trihydroxybenzoate; 3,4,5-trihydroxybenzoic acid [(2R,3S,4S,5S,6R)-2-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-keto-chromen-3-yl]oxy-4,5-dihydroxy-6-methyl-tetrahydropyran-3-yl] ester; 3,4,5-trihydroxybenzoic acid [(2R,3S,4S,5S,6R)-2-[[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-3-chromenyl]oxy]-4,5-dihydroxy-6-methyl-3-tetrahydropyranyl] ester; Quercitrin-2''-gallate; [(2R,3S,4S,5S,6R)-2-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxochromen-3-yl]oxy-4,5-dihydroxy-6-methyloxan-3-yl] 3,4,5-trihydroxybenzoate; [(2R,3S,4S,5S,6R)-2-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-chromen-3-yl]oxy-4,5-dihydroxy-6-methyl-oxan-3-yl] 3,4,5-trihydroxybenzoate | 600.52 | ||
| TCMBANKIN022158 | Δ5,22-stigmastadien-3-ol | 412.77 | |||
| TCMBANKIN024621 | laurotetanine | NSC106610; 6aalpha 1,2,10-Trimethoxy--Noraporphin-9-ol; Laurotetanin; Laurotetanine; NCGC00385613-01!1,2,10-trimethoxy-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-9-ol; MCULE-5875710476; 6a.alpha.-Noraporphin-9-ol,2,10-trimethoxy-; 9-Hydroxy-1,2,10-trimethoxynoraporphine; 128-76-7; 4,15,16-trimethoxy-10-azatetracyclo[7.7.1.0;{2,7}.0;{13,17}]heptadeca-1(17),2(7),3,5,13,15-hexaen-5-ol; (+)-Laurotetanine; NSC-106610; AC1L6I3A; 4H-Dibenzo[de,g]quinolin-9-ol,5,6,6a,7-tetrahydro-1,2,10-trimethoxy-, (6aS)-; 4,15,16-TRIMETHOXY-10-AZATETRACYCLO[7.7.1.0(2),?.0(1)(3),(1)?]HEPTADECA-1(16),2,4,6,13(17),14-HEXAEN-5-OL; CTK4B6053; SCHEMBL905125; Litsoene; 4H-Dibenzo[de, 5,6,6a,7-tetrahydro-1,2,10-trimethoxy-, (S)-; 1,2,10-trimethoxy-5,6,6a,7-tetrahydro-4h-dibenzo[de,g]quinolin-9-ol; Litsoeine; MolPort-021-804-776; AC1Q56MH | C19H21NO4 | 327.4 g/mol | COC1=C(C2=C3C(CC4=CC(=C(C=C42)OC)O)NCCC3=C1)OC |
| TCMBANKIN026357 | austrobailignan-5 | C20H22O4 | 326.39 | CC(CC1=CC2=C(C=C1)OCO2)C(C)CC3=CC4=C(C=C3)OCO4 | |
| TCMBANKIN026989 | saucernelignan-8 | 732.94 | |||
| TCMBANKIN028541 | Linderazulene | CHEMBL503851; 489-79-2; Azuleno[6,5-b]furan, 3,5,8-trimethyl- (6CI,7CI,8CI,9CI); 1,5,8-trimethylazuleno[6,5-b]furan; 3,5,8-Trimethylazuleno[6,5-b]furan; azuleno[6,5-b]furan, 3,5,8-trimethyl-; linderazulene; AC1LCUV1; CTK1D6315; 1,5,8-trimethylazuleno[6,7-b]furan; DTXSID20349625 | C15H14O | 210.27 | CC1=C2C=C3C(=COC3=CC(=C2C=C1)C)C |
| TCMBANKIN028556 | dehydrolindestrenolide | (8aS)-3,8a-dimethyl-5-methylidene-4a,6-dihydro-4H-benzo[f][1]benzofuran-2-one; AC1NSUB7 | C15H16O2 | CC1=C2CC3C(=C)CC=CC3(C=C2OC1=O)C | |
| TCMBANKIN032125 | saucernelignan-7 | 716.89 | |||
| TCMBANKIN032259 | linderol ester | ||||
| TCMBANKIN032920 | isolinderoxide | isolind-eroxide | C16H20O2 | 244.33 | CC1=C2CC3=C(CC2C4C1C4)OC=C3COC |
| TCMBANKIN033181 | lindestrenolide | AC1NSXL7; (8aS)-3,8a-dimethyl-5-methylidene-4a,6,9,9a-tetrahydro-4H-benzo[f][1]benzofuran-2-one; lindestreno-lide | C15H18O2 | 230.3 g/mol | CC1=C2CC3C(=C)CC=CC3(CC2OC1=O)C |
| TCMBANKIN035436 | lindenenone | C17424; CHEBI:81078; Lindenenone; 26379-19-1 | C15H16O2 | 228.29 g/mol | CC1=COC2=C1C(=O)C3=C(C4CC4C3(C2)C)C |
| TCMBANKIN036845 | isoquercitrin | BDBM84979; FT-0627504; ISOQUERCITRIN | C21H20O12 | 464.376 | C1(c2c([H])c([H])c(O[H])c(O[H])c2[H])=C(O[C@]3([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]3([H])O[H])C(=O)c4c(c([H])c(O[H])c([H])c4O[H])O1 |
| TCMBANKIN036895 | SAUCHINONE | SCHEMBL1498622; sauchinone; CHEMBL520054; AKOS030631736; 177931-17-8; ZINC34647724; J-011331; AK683700; Y0181; CTK8G3055; (1S,12R,13S,14R,16R,23R)-13,14-DIMETHYL-2,6,8,20,22-PENTAOXAHEXACYCLO[10.10.1.0(1),(1)?.0(3),(1)(1).0?,?.0(1)?,(2)(3)]TRICOSA-3,5(9),10,18-TETRAEN-17-ONE; MolPort-027-720-909 | C20H20O6 | 356.37 | CC1CC2C3C(C1C)C4=CC5=C(C=C4OC36C(=CC2=O)OCO6)OCO5 |
| TCMBANKIN037185 | Saucerneol C | 4-[(2S,3R,4R,5S)-5-[4-[2-(1,3-benzodioxol-5-yl)-2-hydroxy-1-methyl-ethoxy]-3-methoxy-phenyl]-3,4-dimethyl-tetrahydrofuran-2-yl]-2-methoxy-phenol | 522.6 g/mol | ||
| TCMBANKIN037565 | saururin a | CHEMBL491385 | C21H24O5 | 356.4 g/mol | CC(CC1=CC2=C(C=C1O)OCO2)C(C)CC3=C(C=C4COCC4=C3)O |
| TCMBANKIN038242 | Saucernetin 8 | 732.9 g/mol | |||
| TCMBANKIN038584 | Manassantin A | Manassantin A; BDBM50147176; 1-(3,4-Dimethoxy-phenyl)-2-[4-((2S,3R,4R,5S)-5-{4-[2-(3,4-dimethoxy-phenyl)-2-hydroxy-1-methyl-ethoxy]-3-methoxy-phenyl}-3,4-dimethyl-tetrahydro-furan-2-yl)-2-methoxy-phenoxy]-propan-1-ol; CHEMBL316331; 1-(3,4-dimethoxyphenyl)-2-[4-[(2S,3R,4R,5S)-5-[4-[2-(3,4-dimethoxyphenyl)-2-hydroxy-1-methyl-ethoxy]-3-methoxy-phenyl]-3,4-dimethyl-tetrahydrofuran-2-yl]-2-methoxy-phenoxy]propan-1-ol; 2,2'-[(3alpha,4beta-Dimethyltetrahydrofuran-2alpha,5beta-diyl)bis(3-methoxy-1,4-phenylene)bisoxy]bis(1-(3,4-dimethoxyphenyl)-1-propanol) | 732.9 g/mol | ||
| TCMBANKIN039299 | Manassantin B | CHEMBL321124; 1-(1,3-benzodioxol-5-yl)-2-[4-[(2S,3R,4R,5S)-5-[4-[2-(3,4-dimethoxyphenyl)-2-hydroxy-1-methyl-ethoxy]-3-methoxy-phenyl]-3,4-dimethyl-tetrahydrofuran-2-yl]-2-methoxy-phenoxy]propan-1-ol; 1-(1,3-Benzodioxole-5-yl)-2-[2-methoxy-4-[(2S)-3alpha,4beta-dimethyl-5beta-[3-methoxy-4-[1-methyl-2-(3,4-dimethoxyphenyl)-2-hydroxyethoxy]phenyl]tetrahydrofuran-2alpha-yl]phenoxy]-1-propanol; 2-(4-{(2S,3R,4R,5S)-5-[4-(2-Benzo[1,3]dioxol-5-yl-2-hydroxy-1-methyl-ethoxy)-3-methoxy-phenyl]-3,4-dimethyl-tetrahydro-furan-2-yl}-2-methoxy-phenoxy)-1-(3,4-dimethoxy-phenyl)-propan-1-ol; BDBM50147177 | 716.8 g/mol | ||
| TCMBANKIN039660 | saucerneol a | C32H40O8 | 552.7 g/mol | CC1C(C(OC1C2=CC(=C(C=C2)OC)OC)C3=CC(=C(C=C3)OC(C)C(C4=CC(=C(C=C4)OC)OC)O)OC)C | |
| TCMBANKIN040769 | saucerneol d | CC1C(C(OC1C2=CC3=C(C=C2)OCO3)C4=CC(=C(C=C4)OC(C)C(C5=CC(=C(C=C5)OC)OC)O)OC)C | |||
| TCMBANKIN041129 | Sauristolactam | AC1L2YEP; 14-HYDROXY-15-METHOXY-10-METHYL-10-AZATETRACYCLO[7.6.1.0(2),?.0(1)(2),(1)?]HEXADECA-1,3,5,7,9(16),12,14-HEPTAEN-11-ONE; CHEMBL512443; ACMC-20msvz; Sauristolactam; CTK0I2486; 128533-02-8; 2-Hydroxy-1-methoxy-5-methyldibenz(cd,f)indol-4(5H)-one; Saurolactam; Dibenz(cd,f)indol-4(5H)-one, 2-hydroxy-1-methoxy-5-methyl-; DTXSID80155921 | 279.29 g/mol | ||
| TCMBANKIN041666 | Machilin D | machilin d | C20H24O5 | 344.4 | CC=CC1=CC(=C(C=C1)OC(C)C(C2=CC(=C(C=C2)O)OC)O)OC |
| TCMBANKIN041935 | linderalactone | ST24035668; LWCKQMHMTSRRAA-QGQQYVBWSA-N; C17425; AKOS015897170; I07-0309; Germacra-1(10),4,7,11-tetraen-15-oic acid, 8,12-epoxy-6.alpha.-hydroxy-, .gamma.-lactone, (E)-(+)-; Linderalactone; MCULE-1529191421; 6H-4,7-Methenofuro[3,2-c]oxacycloundecin-6-one, 4,8,9,12-tetrahydro-3,11-dimethyl-, [R-(E)]-; MolPort-005-945-802; 6H-4,7-Methenofuro(3,2-c)oxacycloundecin-6-one, 4,8,9,12-tetrahydro-3,11-dimethyl-, (4R,10E)-; 857366-20-2; 728L610; 728-61-0; AK103578; isolinderalactone; (R,E)-3,11-Dimethyl-8,9-dihydro-4H-4,7-(metheno)furo[3,2-c][1]oxacycloundecin-6(12H)-one; 32663-41-5; ZINC13532008; NCGC00385309-01_C15H16O3_(1R)-3,8-Dimethyl-5,14-dioxatricyclo[10.2.1.0~2,6~]pentadeca-2(6),3,8,12(15)-tetraen-13-one; 6H-4,7-Methenofuro(3,2-c)oxacycloundecin-6-one, 4,8,9,12-tetrahydro-3,11-dimethyl-, (R-(E))-; CHEMBL1080239; (1R,8E)-3,8-DIMETHYL-5,14-DIOXATRICYCLO[10.2.1.0(2),?]PENTADECA-2(6),3,8,12(15)-TETRAEN-13-ONE; NP-013325; AJ-64075; CHEBI:69074; Germacra-1(10),4,7,11-tetraen-15-oic acid, 8,12-epoxy-6alpha-hydroxy-, gamma-lactone, (E)-(+)-; 1312AC | C15H16O3 | 244.29 | CC1=CCCC2=CC(C3=C(C1)OC=C3C)OC2=O |
| TCMBANKIN042572 | Taraxasteryl palmitate | 665.13 | |||
| TCMBANKIN043417 | Quercitrin-2''-gallate | ||||
| TCMBANKIN043806 | neolinderalactone | C15H16O3 | 244.29 | CC1=CCCC2=CC(C3=C(C1)OC=C3C)OC2=O | |
| TCMBANKIN044000 | Saucerneol B | 4-[(2S,3S,4S,5R)-5-[4-[2-hydroxy-2-(4-hydroxy-3-methoxy-phenyl)-1-methyl-ethoxy]-3-methoxy-phenyl]-3,4-dimethyl-tetrahydrofuran-2-yl]-2-methoxy-phenol | 524.6 g/mol | ||
| TCMBANKIN044459 | Saucerneol E | 522.6 g/mol | |||
| TCMBANKIN045306 | saucernetin 7 | C48H54O12 | 822.9 g/mol | CC1C(C(OC1C2=CC(=C(C=C2)C3=CC(=C(C=C3)OC(C)C(C4=CC5=C(C=C4)OCO5)O)OC)OC)C6=CC(=C(C=C6)OC(C)C(C7=CC(=C(C=C7)OC)OC)O)OC)C | |
| TCMBANKIN046503 | lindestrene | AC1NSXL4; SCHEMBL13772561; (8aS)-3,8a-dimethyl-5-methylidene-4,4a,6,9-tetrahydrobenzo[f][1]benzofuran | C15H18O | 214.3 | CC1=COC2=C1CC3C(=C)CC=CC3(C2)C |
| TCMBANKIN048170 | 4-Methoxyphenanthrene-2,3,6,7-tetrol | 272.25 g/mol | |||
| TCMBANKIN048331 | strychnistenolide | C15H18O4 | 262.3 g/mol | CC1=C2C(C3C(=C)C4CC4C3(CC2(OC1=O)O)C)O | |
| TCMBANKIN048415 | isolindleyin | C23H26O11 | 478.446 | [C@]1([H])(O[H])[C@@]([H])(C([H])([H])OC(=O)c2c([H])c(O[H])c(O[H])c(O[H])c2[H])O[C@@]([H])(Oc3c([H])c([H])c(C([H])([H])C([H])([H])C(=O)C([H])([H])[H])c([H])c3[H])[C@]([H])(O[H])[C@@]1([H])O[H] | |
| TCMBANKIN058130 | quercetin-３-Ｏ-galactoside | hyperin; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one; SMR000466394; C10073; ACon1_000623; Quercetin 3-O-beta-D-galactopyranoside; Quercetin-3-O-galactoside;p Hyperin; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3-(beta-D-galactopyranosyloxy)-5,7-dihydroxy-; 482-36-0; Hyperin; Quercetin 3-galactoside; AIDS026341; Hyperasid; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-4-chromenone; NSC 407304; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-chromone; Quercetin-3-O-galactoside; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-chromen-4-one; Hyperozide; AIDS-026341; MLS000759538; Quercetin 3-D-galactoside; EINECS 207-580-6; Quercetin-3-galactoside; Hyperin (8CI); Hyperoside; 2-(3,4-Dihydroxyphenyl)-3-(beta-D-galactopyranosyloxy)-5,7-dihydroxy-4H-1-benzopyran-4-one; 83388_FLUKA; MEGxp0_000392; Hyperosid; Quercetin 3-beta-D-galactopyranoside | C21H19O12- | 463.4 g/mol | C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(C(O4)CO)O)O)O)O)[O-] |
| TCMBANKIN058135 | Polystachoside | quercetin-3-xyloside;4H-1-Benzopyran-4-one, 3-(alpha-L-arabinofuranosyloxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-; 572-30-5; Avicularin; 3-[[(2S,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)-2-tetrahydrofuranyl]oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-chromenone; 3-[(2S,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-chromen-4-one; 4H-1-Benzopyran-4-one, 3-(.alpha.-L-arabinofuranosyloxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-; 3-[(2S,3R,4R,5S)-3,4-dihydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-chromone; 3-[(2S,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-chromen-4-one; 158560-11-3; 3-[(2S,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromen-4-one; 3-[(2S,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-2-(3,4dihydroxyphenyl)-5;hydroxy-7;methoxy;chromen-4;one;Polystachoside;avicularin;aricularin;3-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-chromen-4-one; 3-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromen-4-one; 3-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-chromen-4-one; polystachoside; 3-[(2R,3S,4S,5R)-3,4-dihydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-chromone; 3-[[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-tetrahydrofuranyl]oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-chromenone | C20H18O11 | 434.35 | C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(O4)CO)O)O)O)O |
| TCMBANKIN059439 | Machilin D | C20H24O5 | 344.4 g/mol | CC=CC1=CC(=C(C=C1)OC(C)C(C2=CC(=C(C=C2)O)OC)O)OC | |
| TCMBANKIN059805 | strychnistenolide 6-o-acetate | CC1=C2C(C3C(=C)C4CC4C3(CC2(OC1=O)O)C)OC(=O)C | |||
| TCMBANKIN059975 | β-humulene | C15H24 | 204.35 | CC1=CCC(C=CCC(=C)CCC1)(C)C | |
| TCMBANKIN059999 | beta-Chamigrene | C15H24 | 204.35 g/mol | CC1=CCC2(CC1)C(=C)CCCC2(C)C | |
| TCMBANKIN060024 | thunbergol | C20H34O | 290.48 | CC1=CCCC(C=CC(CCC(=CCC1)C)C(C)C)(C)O | |
| TCMBANKIN060036 | neolinderalactone | C15H16O3 | 244.29 | CC1=CCCC2=CC(C3=C(C1)OC=C3C)OC2=O | |
| TCMBANKIN060053 | linderene | C15H18O2 | 230.3 g/mol | CC1=COC2=C1C(C3C(=C)C4CC4C3(C2)C)O | |
| TCMBANKIN060160 | quercitrin | C21H20O11 | 448.4 g/mol | CC1C(C(C(C(O1)OC2=C(OC3=CC(=CC(=C3C2=O)O)O)C4=CC(=C(C=C4)O)O)O)O)O | |
| TCMBANKIN060264 | rutin | C27H30O16 | 610.5 g/mol | CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC(=C(C=C5)O)O)O)O)O)O)O)O | |
| TCMBANKIN060290 | Galgravin;di-o-methyltetrahydrofuriguaiacin b;(?)-galbelgin;saucernetin;(±)-galgravin;Veraguensin;(+)-galbelgin | C22H28O5 | 372.45 | CC1C(C(OC1C2=CC(=C(C=C2)OC)OC)C3=CC(=C(C=C3)OC)OC)C | |
| TCMBANKIN060738 | 1,4-dimethyl-7-ethylazulene | C14H16 | 184.28 g/mol | CCC1=CC2=C(C=CC2=C(C=C1)C)C | |
| TCMBANKIN060937 | linderic acid | C12H22O2 | 198.3 g/mol | CCCCCCCC=CCCC(=O)O | |
| TCMBANKIN060978 | Mnk | C11H22O | 170.29 | CCCCCCCCCC(=O)C | |
| TCMBANKIN061246 | strychnilactone;strychno-lactone | C17H24O6 | 324.4 g/mol | CCOC(=O)C(=C1C(C2C(C3CC3C2(OC1=O)C)(C)CO)O)C | |
| TCMBANKIN061554 | aristolactam aii | NSC615450; Dibenz[cd,f]indol-4(5H)-one,2-hydroxy-1-methoxy-; 53948-07-5; Aristolactam-aii; Dibenz(cd,f)indol-4(5H)-one, 2-hydroxy-1-methoxy-; DTXSID50202234; aristololactam A II; 14-HYDROXY-15-METHOXY-10-AZATETRACYCLO[7.6.1.0(2),?.0(1)(2),(1)?]HEXADECA-1(16),2(7),3,5,8,12,14-HEPTAEN-11-ONE; ZINC1612828; Dibenz[cd,f]indol-4(5H)-one, 2-hydroxy-1-methoxy-; CHEMBL390368; MolPort-039-141-798; AC1L3XKK; CCRIS 2996; 9099AF; AKOS028108588; Aristolactam AII; NSC-615450; aristololactam A II; aristolactam a | C16H11NO3 | 265.26 g/mol | COC1=C(C=C2C3=C1C4=CC=CC=C4C=C3NC2=O)O |
| TCMBANKIN061558 | laurolitsine | (+)-Norboldine; CHEMBL487388; AC1L2JVN; 568-39-8; LS-97013; Dimethoxy-1,10 dihydroxy-2,9 nor-aporphine; Laurolistine; [(+)-norboldine]; MFCD06809897; UNII-5MT88IS14F; 6a-alpha-NORAPORPHINE-2,9-DIOL, 1,10-DIMETHOXY-; 890L186; (S)-1,10-Dimethoxy-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-2,9-diol; API0008028; Norboldine; Dimethoxy-1,10 dihydroxy-2,9 nor-aporphine [French]; 4H-Dibenzo[de,g]quinoline-2,9-diol, 5,6,6a,7-tetrahydro-1,10-dimethoxy-, (6aS)-; DTXSID30207641; C16984; 4H-Dibenzo(de,g)quinoline-2,9-diol, 5,6,6a,7-tetrahydro-1,10-dimethoxy-; Laurolitsine; 5890-18-6; 5MT88IS14F; D09GXL; BDBM50292446; (9S)-4,16-DIMETHOXY-10-AZATETRACYCLO[7.7.1.0(2),?.0(1)(3),(1)?]HEPTADECA-1(17),2(7),3,5,13,15-HEXAENE-5,15-DIOL; CHEBI:66557; ZINC2559362; 1,10-Dimethoxy-6a-alpha-noraporphine-2,9-diol; (6aS)-1,10-dimethoxy-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-2,9-diol; Norboldine; 1,10-Dimethoxy-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-2,9-diol; AIDS161652; 4H-dibenzo[de,g]quinoline-2,9-diol, 5,6,6a,7-tetrahydro-1,10-dimethoxy-; Dimethoxy-1,10 dihydroxy-2,9 nor-aporphine [French]; 4H-Dibenzo[de,g]quinoline-2,9-diol, 5,6,6a,7-tetrahydro-1,10-dimethoxy-, (6aS)-; AIDS-161652; 6a-alpha-NORAPORPHINE-2,9-DIOL, 1,10-DIMETHOXY-; 4H-Dibenzo(de,g)quinoline-2,9-diol, 5,6,6a,7-tetrahydro-1,10-dimethoxy-; Laurolitsine; 5890-18-6; 1,10-Dimethoxy-6a-alpha-noraporphine-2,9-diol; norboldine; InChI=1/C18H19NO4/c1-22-15-8-11-10(7-13(15)20)5-12-16-9(3-4-19-12)6-14(21)18(23-2)17(11)16/h6-8,12,19-21H,3-5H2,1-2H; 568-39-8 | C18H19NO4 | 313.3 g/mol | COC1=C(C=C2CC3C4=C(C2=C1)C(=C(C=C4CCN3)O)OC)O |
| TCMBANKIN061677 | Cepharanone B | Aristololactam bii; 37326-16-2; Dibenz[cd,f]indol-4(5H)-one, 1,2-dimethoxy-; Dibenz(cd,f)indol-4(5H)-one, 1,2-dimethoxy-; cepharanone b; 53948-09-7; AIDS224741; AIDS-224741 | C17H13NO3 | 279.29 | COC1=C(C2=C3C(=C1)C(=O)NC3=CC4=CC=CC=C42)OC |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab